Your browser doesn't support javascript.
loading
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]. / Prévention de la fibrose et du cancer du foie liés au virus de l'hépatite B en Afrique - Le projet Prolifica.
Cohen, Damien; Shimakawa, Yusuke; Ndow, Gibril; Sow, Amina; Tamba, Saydiba; Njie, Ramou; Lo, Gora; Ghosh, Sumantra; Toure-Kane, Coumba; Ka, Mourtalla; Mboup, Souleymane; Okeke, Edith; Toure, Souleymane; Diop, Madoky; D'Alessandro, Umberto; Taylor-Robinson, Simon; Mendy, Maimuna; Zoulim, Fabien; Thursz, Mark R; Lemoine, Maud; Chemin, Isabelle.
Afiliação
  • Cohen D; Inserm U1052, CNRS UMR 5286, Centre de recherche en cancérologie de Lyon (CRCL), Université de Lyon (UCBL), 151, cours Albert Thomas, 69008 Lyon, France.
  • Shimakawa Y; Unité d'Épidémiologie des Maladies Émergentes, Institut Pasteur, Paris, France.
  • Ndow G; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Sow A; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Tamba S; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Njie R; Medical Research Council Laboratories, The Gambia Unit, Fajara, Gambie.
  • Lo G; Department of bacteriology and Virology, CHU Le Dantec, Dakar, Sénégal.
  • Ghosh S; Inserm U1052, CNRS UMR 5286, Centre de recherche en cancérologie de Lyon (CRCL), Université de Lyon (UCBL), 151, cours Albert Thomas, 69008 Lyon, France.
  • Toure-Kane C; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Ka M; Department of bacteriology and Virology, CHU Le Dantec, Dakar, Sénégal.
  • Mboup S; Department of bacteriology and Virology, CHU Le Dantec, Dakar, Sénégal.
  • Okeke E; Department of Internal Medicine, Jos University Teaching Hospital, Jos, Nigéria.
  • Toure S; Department of bacteriology and Virology, CHU Le Dantec, Dakar, Sénégal.
  • Diop M; Department of bacteriology and Virology, CHU Le Dantec, Dakar, Sénégal.
  • D'Alessandro U; International Agency for Research on Cancer (IARC), Lyon, France.
  • Taylor-Robinson S; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Mendy M; International Agency for Research on Cancer (IARC), Lyon, France.
  • Zoulim F; Inserm U1052, CNRS UMR 5286, Centre de recherche en cancérologie de Lyon (CRCL), Université de Lyon (UCBL), 151, cours Albert Thomas, 69008 Lyon, France.
  • Thursz MR; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Lemoine M; Division of Digestive Diseases, St Mary's Hospital, Imperial College London, London, Royaume-Uni.
  • Chemin I; Inserm U1052, CNRS UMR 5286, Centre de recherche en cancérologie de Lyon (CRCL), Université de Lyon (UCBL), 151, cours Albert Thomas, 69008 Lyon, France.
Med Sci (Paris) ; 35(5): 431-439, 2019 May.
Article em Fr | MEDLINE | ID: mdl-31115326
Despite the existence of an effective vaccine, HBV infects 257 million people worldwide and is the cause of the majority of HCC. With an annual mortality rate of 887 000 patients in 2015, this cancer is the second deadliest. Low-income countries such as ones in sub-Saharan Africa are the most at risk due to the limited access to healthcare. To overcome this and born from an international research collaboration within an EU project, the Prolifica study aimed at evaluating a screen-and-treat program to prevent HBV complications, and more particularly HCC. Based on communities, facilities and hospitals HBsAg+ detection, the study lasted from 2011 to 2016. From the "cost effectiveness" feasibility of such a program to the development of simple scores for antiviral treatment, Prolifica uncovered data of crucial importance in a region with low HBV infection awareness, transmissions modes and prevention means which could have impacts on public health policies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: Africa Idioma: Fr Revista: Med Sci (Paris) Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: Africa Idioma: Fr Revista: Med Sci (Paris) Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França